80 related articles for article (PubMed ID: 823307)
1. Treatment of experiment delayed cerebral arterial spasm with a beta2-adrenergic stimulator and a phosphodiesterase inhibitor.
Norwood CW; Poole J; Moody D
J Neurosurg; 1976 Nov; 45(5):491-7. PubMed ID: 823307
[TBL] [Abstract][Full Text] [Related]
2. Experimental cerebral vasospasm and cyclic adenosine monophosphate (c-AMP).
Kim J; Flamm ES; Lin J
Invest Radiol; 1975; 10(3):239-43. PubMed ID: 166052
[TBL] [Abstract][Full Text] [Related]
3. Delayed cerebral vasospasm is not reversible by aminophylline, nifedipine, or papaverine in a "two-hemorrhage" canine model.
Varsos VG; Liszczak TM; Han DH; Kistler JP; Vielma J; Black PM; Heros RC; Zervas NT
J Neurosurg; 1983 Jan; 58(1):11-7. PubMed ID: 6847896
[TBL] [Abstract][Full Text] [Related]
4. Cerebral arterial spasm. II. Etiology and treatment of experimental cerebral vasospasm.
Morooka H
Acta Med Okayama; 1978 Apr; 32(1):39-49. PubMed ID: 207156
[TBL] [Abstract][Full Text] [Related]
5. Phosphodiesterase inhibitors and cerebral vasospasm.
Flamm ES; Kim J; Lin J; Ransohoff J
Arch Neurol; 1975 Aug; 32(8):569-71. PubMed ID: 168844
[TBL] [Abstract][Full Text] [Related]
6. Proceedings: Successful treatment of delayed arterial spasm in the rhesus monkey after subarachnoid haemorrhage.
Norwood CW; Poole GJ; Moody D; Alexander E
J Neurol Neurosurg Psychiatry; 1975 Apr; 38(4):404. PubMed ID: 237988
[No Abstract] [Full Text] [Related]
7. [Cerebral vasospasm. The cerebral arterial spasm of subarachnoid hemorrhage--a new hemodynamic dimension].
Pendefunda L; Georgescu EM
Rev Med Chir Soc Med Nat Iasi; 1988; 92(4):649-54. PubMed ID: 3253916
[No Abstract] [Full Text] [Related]
8. Physiological considerations important for the management of vasospasm.
Sundt TM; Szurszewski J; Sharbrough FW
Surg Neurol; 1977 May; 7(5):259-67. PubMed ID: 324008
[TBL] [Abstract][Full Text] [Related]
9. A comparison of intravenous aminophylline and salbutamol in the treatment of severe bronchospasm.
Beswick K; Davies J; Davey AJ
Practitioner; 1975 Apr; 214(1282):561-566. PubMed ID: 1096127
[TBL] [Abstract][Full Text] [Related]
10. Aminophylline plus nitroprusside and dopamine for treatment of cerebral vasospasm. A preliminary report.
Levy WJ; Bay JW; Sawhny B; Tank T
J Neurosurg; 1982 May; 56(5):646-9. PubMed ID: 7069476
[No Abstract] [Full Text] [Related]
11. Additive interaction of aminophylline and salbutamol in asthma: an in vivo study using dose-response curves.
Leopold D; Handslip P
J Int Med Res; 1979; 7 Suppl 1():52-5. PubMed ID: 374165
[TBL] [Abstract][Full Text] [Related]
12. Reversal of experimental delayed cerebral vasospasm by angiotensin-converting enzyme inhibition.
Gavras H; Andrews P; Papadakis N
J Neurosurg; 1981 Dec; 55(6):884-8. PubMed ID: 6170740
[TBL] [Abstract][Full Text] [Related]
13. Treatment of cerebral vasospasm by control of cyclic adenosine monophosphate.
Flamm ES; Ransohoff J
Surg Neurol; 1976 Oct; 6(4):223-6. PubMed ID: 184555
[TBL] [Abstract][Full Text] [Related]
14. Aminophylline and isoproterenol in the treatment of cerebral vasopasm.
Fleischer AS; Raggio JF; Tindall GT
Surg Neurol; 1977 Aug; 8(2):117-21. PubMed ID: 888087
[TBL] [Abstract][Full Text] [Related]
15. Phosphodiesterase inhibitors and cerebral vasospasm.
Flamm ES; Kim J; Lin J; Ransohoff J
Trans Am Neurol Assoc; 1974; 99():137-40. PubMed ID: 4377047
[No Abstract] [Full Text] [Related]
16. A primate model of chronic cerebral vasospasm.
Frazee JG
Stroke; 1982; 13(5):612-4. PubMed ID: 7123592
[TBL] [Abstract][Full Text] [Related]
17. Influence of vagal input on cerebral blood flow in monkeys and dogs after experimental cerebral vasospasm.
Ryba M; Głowicki K; Zalewski W; Januszewski S; Kukwa A
Acta Neurobiol Exp (Wars); 1985; 45(5-6):163-71. PubMed ID: 4096279
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of medical treatment (isoproterenol + aminophylline) of aneurysm rupture spasm].
George B; Muzard O; Begue T; Roux FX; Goldstein A; Ragueneau JL
Neurochirurgie; 1984; 30(4):273-6. PubMed ID: 6472552
[TBL] [Abstract][Full Text] [Related]
19. Prevention of experimental subarachnoid hemorrhage-induced intracranial arterial vasonecrosis with phosphodiesterase inhibitor phthalazinol (EG-626).
Alksne JF; Branson PJ
Stroke; 1979; 10(6):638-44. PubMed ID: 118551
[TBL] [Abstract][Full Text] [Related]
20. Use of nimodipine for prevention and treatment of cerebral arterial spasm in patients with subarachnoid hemorrhage.
Welty TE
Clin Pharm; 1987 Dec; 6(12):940-6. PubMed ID: 3322639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
